Element Introduces New Element LoopSeq™ Long-Read Sequencing Kits Designed for the AVITI™ System
Retrieved on:
Thursday, November 10, 2022
SAN DIEGO, Nov. 10, 2022 /PRNewswire/ -- Element Biosciences, Inc.— developer of an innovative DNA sequencing platform disrupting the genomics industry — today announced the availability of its Element LoopSeq long-read sequencing technology kits for AVITI, giving the Element AVITI System the power of both short- and long-read sequencing on the same instrument. Element is the first company to own a general purpose long-read technology that runs on its native short-read sequencer.
Key Points:
- SAN DIEGO, Nov. 10, 2022 /PRNewswire/ -- Element Biosciences, Inc. developer of an innovative DNA sequencing platform disrupting the genomics industry today announced the availability of its Element LoopSeq long-read sequencing technology kits for AVITI, givingthe Element AVITI System the power of both short- and long-read sequencing on the same instrument.
- Element LoopSeq is an extraordinarylong-read sequencing chemistry that provides synthetic long-read capabilities on AVITI.
- For microbiome researchers, 16S LoopSeq for AVITI enables full-length 16S sequencing for up to 96 samples on the AVITI system.
- Register here: https://www.elementbiosciences.com/events/webinar-beyond-covid
For more information about Element LoopSeq, other LoopSeq kits and the AVITI System, including detailed specifications, application data, and performance testimonials, visit www.elementbiosciences.com
Element Biosciences is a multi-disciplinary life science company developing disruptive DNA sequencing technology for research and diagnostic markets.